Huiyong Peng

Dr. Huiyong Peng


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YLYingzhao Liu
Yingzhao Liu
XTXinyi Tang
Xinyi Tang
JTJie Tian
Jie Tian
CZChenlu Zhu
Chenlu Zhu
HPHuiyong Peng
Huiyong Peng
Shengjun WangShengjun Wang
Shengjun Wang
Hashimoto’s thyroiditis (HT) is an organ-specific immune disease characterized by the presence of lymphocytic infiltration and serum autoantibodies. Previous studies have confirmed the critical role of Th17 cells in the pathopoiesis of HT patients. Additionally, regulatory T cells (Treg) display a dysregulatory function in autoimmune disease. The purpose of this study is to investigate the alteration of Th17 and Treg cells in HT patients and explore contributing factors. We found there was an increased ratio of Th17/Treg in HT patients and a positive correlation with autoantibodies (anti-TgAb). In addition, there was an increased level of GITRL, which has been demonstrated to be correlated with the increassement of Th17 cells in the serum and thyroid glands of HT patients; the upregulated serum level of GITRL has a positive correlation with the percentage of Th17 cells in HT patients. In summary, an increase in GITRL may impair the balance of Th17/Treg, and contribute to the pathopoiesis of Hashimoto’s thyroiditis.

20 April 2021 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
JLJian Lu
Jian Lu
JWJing Wu
Jing Wu
XXXueli Xia
Xueli Xia
HPHuiyong Peng
Huiyong Peng
Shengjun WangShengjun Wang
Shengjun Wang

15 November 2021 in Frontiers in Immunology
Verified
Journal Article
Open access
JZJunli Zou
Junli Zou
HPHuiyong Peng
Huiyong Peng
YLYingzhao Liu
Yingzhao Liu
Exosomes are extracellular microvesicles (30-150 nm) released from cells that contain proteins, lipids, RNA and DNA. They can deliver bioactive molecules and serve as carriers facilitating cell-cell communication, such as antigen presentation, inflammatory activation, autoimmune diseases (AIDs) and tumor metastasis. Recently, much attention has been attracted to the biology and functions of exosomes in immune regulation and AIDs, including autoimmune thyroid diseases (AITDs). Some studies have shown that exosomes are involved in the occurrence and development of AITDs, but they are still in the preliminary stage of exploration. This review mainly introduces the association of exosomes with immune regulation and emphasizes the potential role of exosomes in AITDs, aiming to provide new research strategies and directions for the pathogenesis and early diagnosis of AITDs.

5 March 2025 in Clinical and Translational Medicine
Verified
Journal Article
Open access
XXXueli Xia
Xueli Xia
HWHaisheng Wu
Haisheng Wu
YCYuxuan Chen
Yuxuan Chen
HPHuiyong Peng
Huiyong Peng
Shengjun WangShengjun Wang
Shengjun Wang
Ferroptosis is an innovative concept defined as a distinct programmed cell death mode regulated by iron‐dependent lipid peroxidation accumulation. This process is governed by numerous energy metabolites such as fatty acids, amino acids and glucose, as well as iron homeostasis. In recent years, increasing studies have been devoted to the crucial effects of ferroptosis in immune cells during the pathogenesis of diseases such as infections, tumours and autoimmune disorders. This review summarises the latest advancements in T‐cell ferroptosis, addresses the key components and mechanism of ferroptosis in T cells during inflammatory conditions and tumour progression, and highlights the potential target for treating related diseases.Key points: Ferroptosis‐related mechanisms significantly affect the biology of CD4+ T‐cell subsets and are further involved in inflammatory diseases. Crosstalk between CD8+ T cells and tumour cells induces ferroptosis in the tumour microenvironment. Glutathione peroxidase 4 loss promotes regulatory T‐cell ferroptosis to enhance anti‐tumour immunity.

23 August 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
JXJie Xing
Jie Xing
CMChangfeng Man
Changfeng Man
YLYingzhao Liu
Yingzhao Liu
ZZZhengdong Zhang
Zhengdong Zhang
HPHuiyong Peng
Huiyong Peng
Tumor development is closely associated with a complex tumor microenvironment, which is composed of tumor cells, blood vessels, tumor stromal cells, infiltrating immune cells, and associated effector molecules. T helper type 17 (Th17) cells, which are a subset of CD4+ T cells and are renowned for their ability to combat bacterial and fungal infections and mediate inflammatory responses, exhibit context-dependent effector functions. Within the tumor microenvironment, different molecular signals regulate the proliferation, differentiation, metabolic reprogramming, and phenotypic conversion of Th17 cells. Consequently, Th17 cells exert dual effects on tumor progression and can promote or inhibit tumor growth. This review aimed to investigate the impact of various alterations in the tumor microenvironment on the antitumor and protumor effects of Th17 cells to provide valuable clues for the exploration of additional tumor immunotherapy strategies.

14 June 2024 in Heliyon
Verified
Journal Article
Open access
QXQian Xu
Qian Xu
JXJie Xing
Jie Xing
SWShengjun Wang
Shengjun Wang
HPHuiyong Peng
Huiyong Peng
YLYingzhao Liu
Yingzhao Liu
The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is a critical innate immune pathway primarily due to its vital DNA sensing mechanism in pathogen defence. Recent research advances have shown that excessive activation or damage to the cGAS-STING pathway can exacerbate chronic inflammatory responses, playing a significant role in metabolic dysfunction and aging, leading to the development of related diseases such as obesity, osteoporosis, and neurodegenerative diseases. This article reviews the structure and biological functions of the cGAS-STING signaling pathway and discusses in detail how this pathway regulates the occurrence and development of metabolic and age-related diseases. Additionally, this article introduces potential small molecule drugs targeting cGAS and STING, aiming to provide new research perspectives for studying the pathogenesis and treatment of metabolic-related diseases.